• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Akoustis Technologies Inc.

    11/8/24 4:31:13 PM ET
    $AKTS
    Telecommunications Equipment
    Utilities
    Get the next $AKTS alert in real time by email
    DEFA14A 1 ea0220568-defa14a_akoustis.htm DEFINITIVE ADDITIONAL MATERIALS

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    SCHEDULE 14A

     

    Proxy Statement Pursuant to Section 14(a) of
    the Securities Exchange Act of 1934

     

    Filed by the Registrant ☒

     

    Filed by a Party other than the Registrant ☐

     

    Check the appropriate box:

     

    ☐Preliminary Proxy Statement

     

    ☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

    ☐Definitive Proxy Statement

     

    ☒Definitive Additional Materials

     

    ☐Soliciting Material under §240.14a-12

     

    AKOUSTIS TECHNOLOGIES, INC.

    (Name of Registrant as Specified In Its Charter)

     

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

     

    Payment of Filing Fee (Check the appropriate box):

     

    ☒No fee required.

     

    ☐Fee paid previously with preliminary materials.

     

    ☐Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     

     

     

     

     

    AKOUSTIS TECHNOLOGIES, INC.

    SUPPLEMENTAL MATERIAL TO PROXY STATEMENT

    FOR THE ANNUAL MEETING OF STOCKHOLDERS

    TO BE HELD ON NOVEMBER 21, 2024

     

    This proxy statement supplement, dated November 8, 2024, supplements the definitive proxy statement on Schedule 14A (together with subsequent supplements, the “Proxy Statement”) of Akoustis Technologies, Inc. (“we”, “our” or the “Company”) that was filed with the Securities and Exchange Commission (the “SEC”) on October 8, 2024, relating to the Company’s 2024 annual meeting of stockholders to be held on November 21, 2024 (the “2024 Annual Meeting”). Except as specifically supplemented by the information contained in this proxy statement supplement, all information set forth in the Proxy Statement continues to apply and should be considered in voting your shares. 

     

    Engagement of Proxy Solicitor

     

    On November 7, 2024, we engaged Kingsdale Shareholder Services, U.S. LLC (“Kingsdale”), to provide supplemental assistance in the solicitation of proxies, including proxy process-related advice and informational support at a cost of $13,500 plus reimbursement of authorized expenses. In addition, we have agreed to indemnify Kingsdale against certain liabilities arising out of or in connection with the engagement. If stockholders have any questions or need assistance with casting or changing their vote, they should contact Kingsdale at 1-888-518-1560 (toll-free) or 917-985-6945 (outside North America).

     

    Important Information

     

    The Company has filed the Proxy Statement with the SEC and has furnished to its stockholders the Proxy Statement in connection with the solicitation of proxies for the 2024 Annual Meeting. The Company advises its stockholders to read the Proxy Statement relating to the 2024 Annual Meeting, as amended and supplemented by this supplement, because it contains important information. Stockholders may obtain a free copy of the Proxy Statement and other documents that the Company files with the SEC at the SEC’s website at www.sec.gov.

     

     

     

     

    Get the next $AKTS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AKTS

    DatePrice TargetRatingAnalyst
    1/4/2024$2.00 → $1.00Overweight → Neutral
    Piper Sandler
    9/6/2023$9.25 → $1.75Buy → Neutral
    B. Riley Securities
    1/24/2023$9.25Buy
    B. Riley Securities
    11/2/2021$18.00 → $13.00Outperform
    Oppenheimer
    More analyst ratings